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BACKGROUND: Altered epigenetics is regarded to play quite a role in many chronic diseases including cancer, diabetes, obesity, dyslipidemia, 
hypertension and neurodegeneration, hence nutrition 
suggested to contribute in epigenetics and disease.
CONTENT: Histone modifications, as a part of epigenetics 
mechanisms, depend on metabolites which acts as cofactors 
or substrates. Fluctuating levels of specific metabolites 
become the direct and rapid mechanisms to influence 
gene activity. Therefore, these metabolites may have a 
role as gatekeepers of chromatin, in chromatin landscape 
modulation as a response to key nutritional cues. Chemical 
modifications of histones and DNA have a critical role in 
epigenetic gene regulation including histone acetylation, 
and DNA methylation. Any mutations from chemical 
modifications affecting on metabolic enzymes such as 
succinate dehydrogenase (SDH), fumarate hydratase 
(FH) and isocitrate dehydrogenase (IDH) can modify the 
epigenetic and drive tumorigenesis via epigenetic regulation.
SUMMARY: As a response to their nutrient environment, 
organisms tend to rapidly alter their gene expression. Many 
evidences showed an epigenetic regulation of chromatin is 
coupled to the changes on metabolites levels due to this kind 
of response. These metabolites will lead the recruitment of 
transcriptional regulatory complexes to DNA, thus clearly 
influencing the dynamic chromatin landscape.
KEYwORDS: metabolites, enzymes, epigenetics, 
chromatin, nutrition
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Abstract
Introduction
The term 'epigenetic' was first coined as changes in phenotype 
without changes in genotype in 1942 by Waddington, a 
British developmental biologist, paleontologist, geneticist, 
embryologist and philosopher, but the mechanism was little 
understood.(1,2) Almost three-quarters of a century after, 
then we know that epigenetic mechanisms do change the 
genotype patterns, and also be inherited, but the alteration 
is not specifically underlying DNA sequence but by 
adapting chromatin as the physiological form of our genetic 
information. Epigenetics aim to stabilize gene expression 
programs by modifying the DNA template, and thereby 
canalize cell-type identities. Researchers have been aware 
about the importance of epigenetic control since long, but 
they still cannot define the enzymatic of distinct chromatin 
states that stimulate or repress gene activity.(3)
 A chromatin was built basically from nucleosome 
core particle, which consist of approximately 147 base 
pairs of DNA wrapped around a histone octamer and each 
contains two copies of histones H2A, H2B, H3 and H4. 
Histone acetylation could be performed on a more open 
chromatin configuration (euchromatin), so it is permissive 
for transcription, while histone deacetylation eager to occur 
on condensed, compacted chromatin (heterochromatin) 
and transcriptional repression. On chromatin, a variety of 
post-translational modifications are expected on the tails 
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of histones H3 and H4 including acetylation, methylation, 
phosphorylation, sumoylation, and ubiquitylation. 
Determining which genes capable of being transcribed is 
influenced by the positions of nucleosomes relative to the 
DNA strand, which are regulated by chromatin remodeling 
complexes such as Switch/Sucrose Non-Fermentable (SWI/
SNF) complexes. Cellular metabolism generates many co-
substrates that regulate the enzymes needed in epigenetic 
gene regulation, thus become a potential link between 
nutrition, metabolism, and gene regulation.(4)
 Chromatin structure can be modified by epigenetic 
mechanisms through DNA methylation, RNA interference, 
histone variants, and post-translational modifications. 
The progressive combination of these four may lock 
the epigenome in specific states, and change the fate and 
physiology of a given cell determination.(5,6) Histone-
modifying enzymes need key metabolites, so the metabolic 
state of a given cell can be interpreted by changing 
chromatin modification patterns. Therefore, a global 
reduction of nuclear acetyl coenzyme A (acetyl-CoA) 
levels decreases histone acetylation, while reduced levels 
of nicotinamide adenine dinucleotide (NAD)+ give the 
opposite effect, which is inhibiting histone deacetylation.
(7,8) Chromatin-modifying enzymes along with this was 
proposed to be the authors of an epigenetic language, but 
we had to explore deeper about what is the real meaning in 
this chromatin written messages. Current studies suggested 
that the nutritional influences on epigenetic can be passed to 
the offspring, adding the idea that histones act as metabolic 
sensors, and these metabolism changes converted into stable 
patterns of gene expression.(6)
histone) proteins, known as lysine acetyltransferases 
(KATs).(11-15)
 Histones and other proteins are deacetylated by 
enzymes known as histone deacetylases (HDACs) or lysine 
deacetylases (KDACs). Opposite from acetylation, the 
histone deacetylation typically results in a more condensed 
chromatin structure that correlates with repressed 
transcription. Due to the catalytic mechanisms, HDACs fall 
into two general groups.(16) Most HDACs (classes I, II and 
IV) use activated water as the nucleophile, whereas class 
III HDACs (also known as sirtuins) use a cofactor, NAD+, 
to catalyze deacetylation.(17) The oxidation of hydrocarbon 
fuels needs NAD+ as a key electron carrier. The discovery 
of sirtuins as NAD+-dependent deacylases suggested a 
link between cellular levels of NAD+ and the regulation of 
chromatin and gene expression.(18) As we know that sirtuin 
could be activated by dietary restriction thus it is proposed 
to promote health and longevity.(19,20) In fasting condition, 
the ketone body β-hydroxybutryate (βOHB) in blood can 
reach low millimolar. βOHB functions to βOHB inhibits 
HDAC1 and HDAC3 (both class 1) and HDAC4 (class II) 
in vitro, suggesting HDAC activity may be physiologically 
inhibited by βOHB during fasting.(21-23) Butyrate knows 
as a product of bacterial fermentation, then this may extend 
the mechanism of gut microbiome to inhibit HDAC activity 
in colonocytes.(24)
 Histones are so abundant in the chromatin so that their 
acetylation and deacetylation may impact. Each histone 
octamer, occupying around 146 bp of DNA, represents 
nearly 20 acetylatable lysines. These acetyl moieties 
have very short half-lives, only about 2-3 min.(25,26) 
suggested that substantial amounts of acetate might be 
stored on histones and liberated by deacetylation.(27,28) 
When released, acetate will be re-captured by acetyl-CoA 
synthetase enzymes, and convert acetate to acetyl-CoA in an 
adenosine triphosphate (ATP)-dependent reaction. Acetate 
then become an important carbon source for cancer cells, 
and is used to synthesize acetyl-CoA in challenging growth 
environments.(28,29)
 Another  modification  of  histone  that  affect 
chromatin is methylation, where specific methylation 
marks can correlate with either active or repressed 
chromatin and this is also linked to nutrition.  All four core 
histones can be methylated, and in some cases, individual 
residues can be either mono-methylated, di-methylated, 
or tri-methylated.(30-34) Methylation is catalyzed by 
histone methyltransferase enzymes (HMTs), which use 
S-adenosylmethionine (SAM) as the methyl donor. Since 
HMTs also target proteins other than histones, they also 
Dietary Control of Chromatin
Studies on budding yeast about nutritional influence on 
chromatin and gene regulation frequently encounter a wide 
variety of growth environments, give ideas that changes 
in nutrient affect the expression of genes that regulate cell 
growth or survival. One example, glucose repletion to a 
starved yeast culture was found to rapidly induce massive 
changes in gene expression on a global scale.(9,10) 
 Histones are acetylated by a group of enzymes 
called histone acetyltransferases (HATs), it is controlled 
by transcription factor-mediated recruitment of HATs to 
gene promoters and regulatory regions. The process use 
acetyl-CoA  as  the  acetyl  donor,  means  the  fluctuation 
concentration of acetyl-CoA also affect the histone 
acetylation. These enzymes can also modify other (non-
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known as lysine methyltransferases (KMTs). SAM is 
synthesized from methionine by methionine adenosyl 
transferase (MAT), called as SAM synthase.  SAM donates 
its methyl group during methylation, and converted to 
S-adenosylhomocysteine (SAH).  SAH is then hydrolyzed 
to  homocysteine,  and  in  a  reaction  that requires  folate 
and cobalamin  (i.e., vitamin B12)  converted  back 
to  methionine.(35)  Therefore,  the  status  of  histone 
methylation  might be  influenced  by  fluctuations  in  SAM 
or  regulators  of  SAM  synthesis.  Moreover,  SAM  levels 
also  influenced by the  methylation  of  arginine  residues 
and  DNA  itself.(36)
 Histones have apparently similar half-lives with 
this modification, so it was seems impossible for histone 
methylation to be reversed, but in 2004, first of several 
histone demethylases (HDMs) was identified.(37-39) These 
enzymes also modify non-histone lysines, so they also 
called as lysine demethylases (KDMs). Two main classes of 
HDMs are the JmjC (Jumonji C domain)-containing HDMs, 
which depend on Fe(II) and α-ketoglutarate, and the lysine-
specific amine oxidases, which are depend on flavin adenine 
dinucleotide (FAD). This finding suggested the dynamic 
character of methylation, estimating the half-lives of methyl 
modifications on histones range from 0.3 to 4 days (40,41), 
significantly longer than acetylation modifications, which 
are on the order of minutes (25,26).
 Demethylation of histones needs both α-ketoglutarate 
(a tricarboxylic acid cycle (TCA) cycle intermediate) 
and iron, Fe(II), and yielding succinate, formaldehyde, 
and carbon dioxide.(39) So, the fluctuations level of 
α-ketoglutarate might influence histone methylation status. 
A manipulation experimental on mouse embryonic stem 
cells proposed a mechanism to maintain pluripotency 
using both glucose and glutamine to maintain high levels 
of intracellular α-ketoglutarate thus promoting both histone 
demethylation and DNA demethylation, affected multiple 
chromatin modifications, including H3K27me3 and ten–
eleven translocation (Tet)-dependent DNA demethylation, 
important for pluripotency-associated genes.(42) 
 The fluctuations in the level of SAM appear to also 
influence pluripotency by affecting H3K4 trimethylation.
(43) Another metabolite that influences histone methylation 
status and gene expression is FAD, which was required as 
a cofactor for lysine-specific amine oxidase class of histone 
demethylases (KDMs), so FAD availability is crucial for 
this regulation.(37) High-fat diet mice’s adipose tissue 
have high FAD levels while the lysergic acid diethylamide 
(LSD)1-targeted genes were repressed, and otherwise it will 
increased when FAD synthesis was inhibited.(44)
Bridging Epigenetics and Metabolism
Cells sense changes in the environment and respond by 
ordering  specific  modulations  to  the  genome  over  a 
variety of signaling components, including proteins with 
histone- and DNA-modifying enzymatic activity.(45) 
Metabolites as a  respond  of  nutrient  sensing  recently 
found to surpass these where metabolites may serve as 
indicators of the metabolic status of the cell and, through 
metabolite-sensitive protein modifications, can modulate 
the activities of signaling proteins, metabolic enzymes 
and transcriptional regulators, generating modifications 
such as acetylation, methylation, glycosylation and 
phosphorylation.(46) Particular metabolites such as 
cytosolic or nuclear acetyl-CoA, even can impact on a 
bigger and meaningful modifications to the biology of the 
cell such as signal transduction and gene expression, as well 
as cellular metabolism itself.(46-49)
 Epigenetic control is close connected with metabolism, 
as proved by findings on the fat mass and obesity-associated 
(FTO) gene. The gene encodes an N6-methyladenosine 
(m6A) demethylase, an enzyme that controls the levels of 
RNA methylation.(50) Single-nucleotide polymorphisms of 
this gene will alter its response to food intake affecting in 
the development of obesity. Some chromosome experiments 
showed the epigenetic impact on this gene where certain 
variants of FTO can physically loop to and interact with 
iroquois homeobox 3 (IRX3), a homeobox gene located 
megabases away from FTO. Thus, manifestation of one 
gene impact in metabolic dysfunction, will affect influences 
the function of a distant gene that implicated in controlling 
body mass.(51,52) Chromatin regulation requires enzymes 
as cofactors for the reactions either attach small chemical 
units (i.e., posttranslational modifications or PTMs) or alter 
nucleosome positioning or composition (i.e., of histone 
variants), to modify DNA or histones. Here, the variable 
levels of cellular metabolites acts as enzyme cofactors 
(Figure 1).(45)
 Metabolism can be simply defined as the set of life-
sustaining chemical reactions in organisms. In metabolism 
process, cell interacts with energy sources, coordinating the 
 Nutritional or dietary control has not been fully 
considered in fundamental regulatory mechanism directly 
linked to human physiology or its role in epigenetic, while 
they may have functions beyond the gene transcription 
regulation, including pH regulation and as carbon sources 
in cancer cells.(36)
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Figure 1. The major cofactors 
involved in enzyme-mediated 
DNA or histone post-translational 
modification (PTM).(45) (Adapted 
with permission from Cold Spring 
Harbour Laboratory Press).
energy intake with its use and storage that supports growth 
and cell division.(27) different enzymes and a variety of 
cofactors of which ATP, NAD, FAD, nicotinamide adenine 
dinucleotide phosphate (NADP), heme, coenzyme a, 
Uridine diphosphate N-acetylglucosamine (UDP-Glc-Nac), 
SAM, and many more were included to drive a highly 
interconnected network of chemical reactions in order to 
maintain metabolic homeostasis (53), enable rapid sense 
and react yielding an adaptation of physiological processes 
to the external stimuli.(54-57) Chromatin serves as a 
platform for epigenetic process, which including receive 
extra and intracellular stimuli and converts them in transient 
or stable transcriptional changes. These performed through 
modifications of both DNA and histone proteins as well as 
gene transcription.(58,59)
 Since acetylation as an epigenetic mechanism was 
known to be reversible, histone and nonhistone acetylation 
rise as the integrating key for physiological processes such 
as metabolism, circadian rhythm and cell cycle, along with 
gene regulation in various organisms.(60) Methylation and 
acetylation of DNA and histone proteins are the chemical 
basis for epigenetics. They are sensitive to cellular metabolic 
in any models from bacteria to humans. The rate of 
modification depends on the availability of one-carbon and 
two-carbon substrates (SAM, acetyl-CoA, and in bacteria 
also acetyl-phosphate). In addition, they are also sensitive to 
demodification enzyme cofactors (α-ketoglutarate, NAD+) 
and structural analog metabolites that function as epigenetic 
enzyme inhibitors (e.g., SAM, 2- hydroxyglutarate). In 
microbes, methylation and acetylation evolved to tailor 
proteins activities to their metabolic environtment, not in 
mammals where the extracellular environment is more 
tightly controlled, the incorporate impact of nutrient and 
metabolic enzyme expression drive the biological outcomes 
such as stem cell fate and cancer.(61)
 Methylation and acetylation can be affected by the 
metabolic environment, for example acetyl-CoA can be 
made from each major category of mammalian nutrients 
(carbohydrates, fats, protein). In mouse liver, fasting 
will impact in a higher free CoA while acetyl-CoA is 
relatively stable (62), suggested a link between dietary 
nutrient consumption, acetyl-CoA levels, and in vivo 
acetylation rates. Deacetylation by sirtuins, however, was 
influenced by levels of their co-substrate NAD+ (relative to 
competitive inhibitors). Even  when deacetylases use only 
water as the sole substrate, still regulated by circulating 
β-hydroxybutyrate.
 Calorie restriction and high-fat diet may promote 
histone deacetylation by potentially promoting high NAD+/
NADH.(63-65) Nicotinamide phosphoribosyltransferase 
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Figure 2. Schematic representation 
of the role of some products of cell 
metabolism. the  gure highlights their 
connections in regulating different 
epigenetic processes. (59) (Adapted with 
permission from Springer).
Regulation of Chromatin and Gene Expression by Metabolic Enzymes and Metabolites
(NAMPT), a key enzyme in mammalian NAD+ synthesis was 
low in high-fat diet-induced diabetic mice. Administration 
of this enzyme restores NAD+, activates SIRT1 and SIRT3, 
and enhances insulin sensitivity (66,67) N-methyltransferase 
(NNMT), the enzyme that consuming NAD+ is up-regulated 
in mouse models of obesity and insulin resistance (68) and 
is overexpressed in many tumors (69). NNMT performing 
dual epigenetic effects, simultaneously depleting SAM and 
NAD+, and thereby impairing methylation and deacetylation 
(68). When fasting, the liver increase in fatty acid oxidation 
and circulating D-β-hydroxybutyrate levels can rise to above 
1 mM. β- hydroxybutyrate increases H3K9 acetylation at the 
promoter of forkhead Box O3A (FOXO3A), a transcription 
factor for oxidative stress resistance genes (21). Low 
carbohydrate diets can promote ketogenesis in order to 
protect neurons from oxidative damage.(70,71)
 Cells can adapt to the new environmental condition 
due to a regulated cross-talk between metabolic pathways 
in the mitochondria and epigenetic mechanisms in the 
nucleus. Harmonized gene expression was accommodated 
by dynamically changes in chromatin, including 
methylation of DNA and posttranslational modifications 
of histones: Acetyl, methyl, and phosphate groups can 
be added by acetyltransferases, methyltransferases, and 
kinases, respectively, to different residues on histones. 
The metabolism and epigenetics crosstalk be held in  two-
way. Any defects in chromatin modulators will affect the 
availability of intermediate metabolites, in turn influencing 
energy metabolism (27), and finally affect epigenetic 
regulation, such as altered nutrient availability regulating 
histone and DNA modifications, circadian biological 
rhythms and cellular replicative aging and senescence.(45)
The knowledge of epigenetic have changed from a series 
of biological phenomena to a functionally dissected 
study field because of the new discoveries regarding 
chromatin-modifying enzymes and associated mechanisms 
that changed chromatin in response to physiological or 
pathological signals.(3) Chromatin plays a key role in the 
changes of  epigenome function (Figure 3). 
 In eukaryotic cells, the genomic DNA is packed 
into chromatin by formation of nucleosomes, where each 
nucleosome core particle is consist of a histone octamer 
wrapped by around 146 base pairs.(72) Eight core histones 
which  consist  of  two  copies  each  of  H2A,  H2B,  H3 
and H4 are grouped together into one histone octamer. 
Histone amino-terminal tails and the globular histone cores 
are susceptive  to  a  wide  array  of  covalent modifications 
(73), such as acetylation, methylation, phosphorylation, 
sumoylation, ubiquitylation, succinylation, glutarylation, 
propionylation, butyrylation, crotonylation, 2-hydroxy-
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isobutyrylation, β-hydroxybutyrylation, malonylation, 
formylation, citrullination, hydroxylation, O-GlcNAcylation 
and ADP ribosylation. These modifications could lead 
to more than 600 post-translational modification sites 
of eukaryotic histones.(74-76) In addition to histones, 
modifications of DNA is also possible, such as methylation 
of the 5-carbon on cytosine residues, which yields 
5-methylcytosine (5mC) in CpG dinucleotides; 5mC is 
oxidized to 5-hydroxymethylcytosine (5hmC), which is 
further oxidized to 5-formylcytosine (5fC) and eventually to 
5-carboxylcytosine (5caC).(77,78) These various chromatin 
modifications alter chromatin structure, which eventually 
regulate the binding process of binding protein to DNA 
and histone. This phenomena will affect the regulation of 
all DNA-based processes in cell, including gene expression, 
DNA replication and DNA damage response.(76,79-81)
 Methylation  is  the  main  chromatin  modification 
which is strongly connected to metabolism. Some 
methyltransferases  are  involved  in  epigenetic  gene 
regulation, such as DNA methyltransferases (DNMTs), 
KMTs and peptidyl-arginine methyltransferases (PRMTs).
(82) These enzymes deposit methyl groups on DNA and 
histones, which end up to complex alterations in chromatin 
accessibility,  transcription  factor  binding and gene 
expression.(83) Methylation is caused by SAM abundance, 
whereby SAM serves as a methyl donor and is synthesized 
from methionine and ATP by MATs.(84) Once SAM donor its 
methyl to the DNA, another metabolite is produced, namely 
SAH, which is a potent inhibitor of all methyltransferases. 
Hence, the methyltransferase activity is dynamically 
regulated by the intracellular ratio of SAM:SAH.(85-87) 
Therefore, the consumption of food which is rich in methyl-
donating nutrients, such as folic acid and vitamin B, could 
induces DNA and histone methylation and influences gene 
expression.(88)
 External influences including food consumption will 
globally change the cofactor concentration in cell, hence 
have a global effect on histone modifications. However, 
collected evidence shows that histone-modifying enzymes 
could also make use of local alterations in metabolite 
concentration to obtain a domain-specific chromatin 
remodeling.(8,89) The landmark finding established that 
histone deacetylation is related to transcriptional repression. 
Taken together, the 1996 HAT and HDAC work provided 
a compelling one–two punch that histone acetylation and 
deacetylation are directly coupled to take turn in turning on 
and turning off the states of gene regulation.(90) Figure 4 
shows molecular hallmarks of epigenetic control and other 
examples for their medical relevance.
 Sir1, a NAD-requiring HDAC is a key protein that is 
necessary of the gene silencing in yeast. Up to now, there are 
seven Sir-2-like enzymes that were identified in mammals 
Figure 3. Key examples of chromatin contribution to epigenome function.(3) (Adapted with permission from Springer Nature).
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Sirtuins As Regulators of Metabolism and Healthspan
cells. They are now known as Sirtuin protein family. Not 
only having distinct cofactor and catalytic requirements to 
the other HDACs, but the Sir2-related HDACs motivate 
more researchers in investigating their functions in 
metabolism and ageing.(45) A great number of enzymes 
depend on the coenzyme NAD+, including two groups of 
chromatin regulators, the class III HDACs (sirtuins) and the 
PARPs (poly-ADP ribose polymerases). The shifting levels 
of a single metabolite may impact independent groups of 
enzymes with different functions. Other enzymes, such 
as HATs, may also be indirectly affected by the changing 
concentrations of NAD+.(6) Levels of NAD+ are regulated 
in a circadian manner, establishing a direct relationship 
between cyclic rhythms and energy metabolism in the cell.
(7,91)
 Both histone and DNA methylation are reversibly 
regulated by dynamic modulation of methyltransferase and 
demethylase activities, and these modulations are directed 
by various metabolites. The production of these metabolites 
is subject to regulation by cell signaling, meanwhile the 
producing enzymes can be subject to mutagenesis, thereby 
determining the biological outcomes. Metabolism and 
DNA-based processes are thightly integrated to manage 
physiological responses to extracellular stimuli, and 
deregulation of these interconnected pathways can have 
profound consequences, which could end up in a disease 
development.(92)
 Exploratory research into more complex human 
disease (such as metabolic and neurodegenerative 
diseases) and habitual functions (such as learning and 
memory) reveals that the responsiveness to combinatorial 
epigenetic therapies as more precise inhibitors, for example 
HDAC inhibitor (HDACi), DNMT Inhibitors (DNMTi), 
inhibitor of bromodomain and extra-termina (iBET) and 
sirtuin inhibitors, are currently being developed. New 
experimental systems are also being used to start analyzing 
the contribution of epigenetics to behavior and phenotypic 
polymorphism in social insects.(93) For metabolic disorders 
and environment-driven adaptations, chromatin is shown to 
be the physiological template to integrate changing inputs.
(45,94,95)
 It is still a great challenge to determine how plastic 
the epigenome is to nutritional challenges and whether 
epigenetic changes triggered by altered metabolic states 
can be reversed. Main metabolic alternations are frequently 
found in cancers, in which cells switch to an anaerobic 
metabolism even in the presence of oxygen. This Warburg 
Effect is accompanied by major changes in gene expression 
profile whose causes are likely to be related to specific 
chromatin-remodeling events. Lately, the genes encoding 
isoforms of the enzyme isocitrate dehydrogenase (IDH)1 
and IDH2 have been found to be mutated in a wide variety 
of tumors. 
 Therefore, an impaired in genes encoding metabolic 
enzymes could directly affect the enzymatic function of 
epigenetic regulators, inducing an increase in histone 
and DNA methylation. The causal relations between IDH 
mutations, alterations in epigenetic modifications, and the 
altered  patterns  of  gene  expression  observed  when 
cancer cells  switch  to  an  anaerobic  metabolism  have 
not  yet been demonstrated. However, it is intriguing to 
speculate that  the  epigenetic  reprogramming  induced  by 
an  aberrant  metabolite  has  an  important  role  in  this 
process.(6)
 It is known that histone and DNA-modifying enzymes 
have essential roles in regulating chromatin structure, 
contributing to both genome integrity and to transcriptional 
regulation. Yet their connection with different metabolic 
pathways is still not being investigated enough. The basic 
role of chromatin-modifying enzymes is also highlighted 
by their connection with several pathologies. For instance, 
several of the discussed enzymes harbor mutations that 
led to a deregulated activity in cancer cells. Similarly, 
metabolism and metabolic pathways also emerge as 
significant regulators of cell homeostasis, playing important 
roles not only in metabolic syndromes but also in the cancer 
biology. The development of cancer or neurodegenerative 
disorders as happens in patients suffering from obesity or 
hyperglycemia is an example on how metabolic syndromes 
are favored by abnormal epigenetic modifications and 
how metabolic changes affect epigenetic mechanisms 
predisposing. This will also be beneficial in predicting 
the effects of pharmacological manipulation of these 
two important cellular processes and in defining specific 
approaches for different pathologies.(59)
The balance among energy intake, utilization and storage 
are necessary for metabolic control. When there is sufficient 
food, the excess energy will stored, so that it can be used 
in times of scarcity. A carefully tuned regulatory and 
evolutionarily conserved program controls these switches 
in nutrient intake, use and storage, involving classical food 
excess signaling pathways, such as insulin growth factor 1 
(IGF1) and target of rapamycin (TOR; mTOR in mammals), 
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Figure 4. Molecular hallmarks of 
epigenetic control and examples for 
their medical relevance.(3) (Adapted 
with permission from Springer Nature).
and food restriction pathways involving AMP-activated 
protein kinase (AMPK) and sirtuins.(96-99)
 As Sir2 was found to be an NAD-dependent HDAC 
(100), it became clear that sirtuins work both as energy 
sensors and as transcriptional effectors by controlling the 
histone acetylation state. Beside that, sirtuins not only 
deacetylate histones, but also a broad range of trascriptional 
regulators, and then controlling their activity. Sirtuins, 
notably SIRT1, have been known for their role in caloric 
restriction, prevention of ageing-related diseases and also 
maintenance of metabolic homeostasis. As a consequence, 
the search for nutriceutical or pharmaceutical sirtuin 
activators was intense and drove to the identification of 
several sirtuin activators. Resveratrol, a polyphenol found 
in  red  grapes,  berries  and  peanuts  received  a  lot of 
attention.(101) Activation of sirtuins is assumed to be 
beneficial not only for metabolism-related diseases, such as 
type 2 diabetes and obesity, but also for neurodegenerative 
diseases, such as Parkinson’s disease and Alzheimer’s 
disease. This is in part because sirtuins stimulate the activity 
of mitochondria and of mitochondrial proteins.
 An analysis on sequence-based phylogenetic divided 
mammalian sirtuins into four classes. SIRT1, SIRT 2 and 
SIRT3 are belong to class II, SIRT4 belongs to class II, 
SIRT5 belongs to class III, meanwhile SIRT6 and SIRT7 
are belong to class IV.(102) In the beginning, sirtuins were 
known as NAD-dependent type III HDACs, as the founding 
member, Sir2 in yeast, silenced specific genomic loci by 
deacetylating histones H3 and H4.(103) Interestingly, 
mammalian sirtuins, notably those in class I, beside targeting 
histones, they also deacetylate a broad range of proteins in 
different subcellular compartments. Moreover, SIRT4 and 
SIRT6 were reported to function as ADP-ribosyltransferases, 
even though SIRT6 also can act as a deacetylase.(104-107) 
SIRT5 was originally reported to deacetylate the urea cycle 
enzyme carbamoyl phosphate synthetase 1 (CPS1) but was 
lately shown to primarily demalonylate and desuccinylate 
proteins, including CPS.(108-110)
 To catalyzed an enzymatic reaction, sirtuins needs 
NAD+ as a substrate, the concentration of which is 
determined by the nutritional state of the cell.(111) For 
example, NAD+ is well positioned to manage the adaptive 
responses to energy stress by modulating the activity of 
sirtuins and their downstream effectors. Sirtuins change 
NAD+ to nicotinamide, which at higher concentrations can 
non-competitively bind and thereby feedback-inhibit the 
sirtuin activity.(112,113) The other by-product of the sirtuin 
deacetylase reaction, O-acetyl-adenosine diphosphate 
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(ADP)-ribose, was also reported to be a signalling molecule 
(114,115), but similarly to nicotinamide, its exact role in 
metabolic control is still unclear.(111,116)
 SIRT3, SIRT4 and SIRT5 localize primarily to 
mitochondria.(117,118) SIRT3 is the major mitochondrial 
deacetylase (119),  and some of its targets have been 
have been known to have important roles in metabolic 
homeostasis. For example, the long-chain acyl CoA 
dehydrogenase (LCAD), a protein involved in fatty acid 
oxidation, is targeted by SIRT3 during prolonged fasting, 
which  results in the activation of fatty acid breakdown.
(120) Deletion of SIRT3 in mice bothers fat breakdown, 
exacerbating diet-induced obesity and rendering them 
sensitive to cold upon fasting.(121) SIRT3 deacetylation 
sites have also been identified in 3-hydroxy-3-methylglutaryl 
CoA synthase 2 (HMGCS2), that regulates the production 
of ketone bodies, an important energy source for the brain 
during the low blood glucose levels.(122) In response to 
caloric restriction, SIRT3 deacetylates and thereby activates 
IDH2, which is relevant in the TCA cycle.(123) SIRT3 also 
activates the TCA cycle enzyme glutamate dehydrogenase 
(GDH) (119), even though the physiological relevance of 
GDH deacetylation is still unknown. Besides that, SIRT3 
deacetylates components of complex I (124), complex 
II (125) and complex III (126), which are involved in 
oxidative phosphorylation (OXPHOS), the final stage of 
mitochondrial aerobic respiration.
 There are some natural compounds that have been 
identified as a SIRT1 activator, this provides further insights 
into sirtuin regulation.(127) Resveratrol also increases 
SIRT1 activity and enhances mitochondrial function in 
mice (128,129), protecting them from put on a high-fat diet, 
resveratrol-treated mice also live longer compared to those 
aren’t.(129,130) Resveratrol also improves mitochondrial 
activity and metabolic control in humans, significantly lower 
resveratrol doses (around 200-fold lower than the doses 
given in mice) resulted in resembling plasma resveratrol 
levels, AMPK activation and physiological effects to those 
observed following resveratrol treatment in mice.(131) 
Some synthetic compounds have also been known could 
activate SIRT1. The most potent of these is SRT1720 (132), 
which is similar to resveratrol in protecting against diet-
induced obesity by improving mitochondrial function (133) 
and extending the lifespan of obese mice (134).
 Sirtuins deacetylate not only histones and several 
transcriptional regulators in the nucleus, but also specific 
proteins in other cellular compartments, such as in the 
cytoplasm and in mitochondria, making them known to 
have roles in different cellular compartments. As a results, 
sirtuins  regulate  fat  and  glucose  metabolism  in  response 
to physiological alterations in energy levels, therefore 
acting as crucial regulators of the network which controls 
energy homeostasis and determines the healthspan.(135)
Epigenetic and Metabolism in Aging Stem Cells
Along with aging, there will also be a decline in tissue 
function, regeneration and repair, which are caused by the 
deterioration of tissue stem cell function. Knowing the 
mechanisms driving stem cell aging and how to counteract 
them is a critical process to enhance tissue repair and 
maintenance during aging. Emerging proof indicates that 
epigenetic modifiers and metabolism regulators interact 
to affect lifespan, suggesting that this mechanism may 
also works with stem cell function with age.(136) Tissue-
specific stem cells are present in virtually every adult tissue 
in mammals and are important for tissue homeostasis and 
repair after injury. The prominent decline in the function 
of stem cell during aging, coupled with a bias in the type 
of differentiated cells they generate, could lead to the 
deterioration in tissue function and diminished capacity for 
tissue repair in elderly. Stem cell function is regulated in 
response to variety of external stimuli, including nutrient 
stress (e.g., starvation or caloric restriction, or high fat 
diets).(137)
 The complexity of stem cell compared to other 
somatic cells, might be complicate people’s understanding 
on the interaction between cellular metabolism and 
chromatin features in stem cells. Stem cells naturally 
give raise to progeny which are vastly different in terms 
of virtually every biological parameter. For instance, 
quiescent stem cells show minimal metabolic activity, have 
few mitochondria and other organelles, and also have a 
minuscule cytoplasmic volume. Meanwhile in contrast, 
proliferating progeny manifest dramatic energetic changes, 
increases in biosynthetic activity, and cell growth. As 
these progeny differentiate into mature, tissue-specific 
cells, there are dramatic structural and functional changes. 
The dynamic interaction between the cellular metabolism 
and the epigenome is important to the control of stem cell 
transitions and function.(136)
 Epigenetic alteration related to somatic stem cell 
aging have been reported for multiple stem cell populations, 
notably hematopoietic stem cells (HSCs) and muscle 
stem cells (MuSCs)/satellite cells.(138,139) In both HSCs 
and MuSCs, there is an age-dependent increase in the 
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repressive histone modification H3K27me3, whereas 
H3K4me3, a mark associated with active genes, displays 
breadth increase in HSCs but in slight intensity decreases 
in quiescent MuSCs along  with age. Shifts in a number 
of other chromatin features, most of which are also altered 
with age, have been known to regulate stem cell function.
(140) For instance, a change in DNA methylation affect 
the differentiation  potential  of  HSC.(141,142)  One 
mediator of  heterochromatin  formation,  namely  H3K9 
methylation, is important for HSC differentiation.(143) 
Meanwhile H4K20 methylation controls MuSC quiescence 
by  promoting  the  formation of facultative heterochromatin.
(144) At last, exceptionally  wide  H3K4me3 domains form 
a signature for  cell  function,  and  these extended  domains 
mark  genes  which  are  crucial  for  the  ability  of  neural 
stem cells  (NSCs)  to self-renew and to differentiate into 
neurons.(145) 
 Thus, selected metabolites could promote long-lasting 
changes in gene expression and stem cell state changes in 
response to environmental stimuli. Given the epigenetic 
alternations associated with stem cell aging, it will be 
interesting to know how the shifting in metabolic regulation 
associated with aging explain these age-related changes in 
chromatin.(136)
 Different metabolites can alter or maintain certain 
epigenetic states, thereby driving long-lasting changes in 
gene expression and modulating stem cell states. Metabolites 
(Acetyl Co-A, NAD, FAD, SAM, etc) serve as cofactor 
for epigenetic enzymes such as sirtuin deacetylases which 
is function as an important modulator for maintaining the 
somatic stem cells homeostasis. During aging process, NAD 
becomes limiting during the aging process, subsequently 
changing global levels of histone acetylation. This will 
activate the stress-responsive genes such as Nrf2 who is 
responsible for modulating redox homeostasis during the 
aging process and stem cells senescence.(146)
 Another example, a-ketoglutarate play its role in 
histone demethylation by functions as a cofactor for both 
Ten-eleven Translocation (TET) enzymes which implicated 
in DNA demethylation and Jumonji family proteins applied 
in histone demethylases, potentially regulating various 
chromatin events in different types of stem cells.(146)
 Whilst several main regulators of lifespan and 
healthspan, such as sirtuins, are directly influenced by 
metabolites, other crucial regulators, including the insulin-
FOXO and the mTOR signaling pathways, are global 
integrators of cellular nutrient and metabolic status. The 
role of these pathways in the control of stem cell fate has 
been widely studied.(147)  The mechanisms of rejuvenation 
The intimate and reciprocal regulation between gene 
expression outputs and cellular metabolic state is 
undoubtedly very useful for the cell. There has been found 
enough proof to suggest that chromatin play a role as a 
metabolic gatekeeper of the genome. The wrapping of DNA 
around histones in a default repressive state might enable 
a cell to closely gather nutrient availability by controlling 
access to the DNA via the requirement of metabolites as 
histone modifiers and the regulation of a variety of cellular 
outputs by controlling the expression of particular modules 
of genes. Several researches that has been done in the past 
few years have placed this complex network of metabolism, 
chromatin architecture, and gene expression at center stage. 
Studies discussed in this review highlight the possibility 
that histone acetylation, deacetylation, methylation and 
demethylation are under the control of several main 
metabolic regulators, namely Acetyl-CoA, NAD+, SAM, 
and α-KG. It is likely more than coincidence that cells 
have chosen to regulate access to their DNA via histone 




of old stem cells could be mediated at least in part by the 
interaction between metabolites and epigenetic regulators. 
Cellular reprogramming has also been known to reset some 
age-dependent phenotypes including the metabolic and 
epigenetic features.(148) Hence, a targeted modification of 
specific  metabolic  and  epigenetic  pathways,  especially 
those  that  happen  in  the  early  the  reprogramming 
process,  could  be  sufficient  to  promote  rejuvenation 
without inducing dedifferentiation. Collectively, the 
knowledge of the  interaction  between  metabolism  and 
epigenetics will be  crucial  to  identify  the  new  strategies 
for  preserving youthful  cellular  function  as  organisms 
age or to counteract age-related dysfunction of stem cells in 
old tissues.(136)
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